1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow caficrestat: new trials by email Literature Review of caficrestat trials Research Report on caficrestat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy AT-001, Placebo - Diabetic Cardiomyopathies | Phase 3 | Active not recruiting | Applied Therapeutics, Inc. | 675 | 2019-09-20 | 2022-12-08 |
Diabetes Mellitus, Type 2 (1) · Diabetic Cardiomyopathies (1)
Applied Therapeutics, Inc. (1)
Australia (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hong Kong (1) · Poland (1) · Spain (1) · United Kingdom (1) · United States (1)
PMID 38302936, PMID 38597864, PMID 38986667, PMID 39095808, PMID 39806375, PMID 39882614, PMID 40315802, PMID 40338768, PMID 42538062